Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes

Recruiting

SuvorexantEfficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes

Sponsor:

Brigham and Women's Hospital

Code:

NCT05593653

Conditions

Insomnia

Diabetes

Menopause

Eligibility Criteria

Sex: Female

Age: 40 - 65

Healthy Volunteers: Not accepted

Interventions

Suvorexant

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-25. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2025-07-25.